School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Susan Modesitt MD, FACOG, FACS

  • Department of Gynecology & Obstetrics
    Professor
  • smodesi@emory.edu

  • Gynecology and Obstetrics
    101 Woodruff Circle, Room 4206
Head shot of Susan Modesitt

Overview

Susan C. Modesitt, MD, FACOG, FACS, is the Chair of the Department of Gynecology and Obstetrics and the Leach Hendee endowed professor in Gynecologic Oncology at Emory University School of Medicine. Prior to being recruited and joining the Emory faculty in 2022 as the Division Director of Gynecologic Oncology and the Gynecologic Team leader in the Winship Cancer Institute, she was an endowed professor and division director of gynecologic oncology at the University of Virginia from 2007-2022.

Dr. Modesitt is a fellow and a Governor of the American College of Surgeons (ACS) and a fellow of the American College of Obstetricians and Gynecologists (ACOG). She has served in multiple national leadership roles and committees for the Society of Gynecologic Oncology, ACS, ACOG, the American Board of Obstetrics and Gynecology, the Foundation for Womens Cancer and the NRG Oncology Group. Dr. Modesitt currently is the Editor-in-Chief of Gynecologic Oncology Reports and a Deputy Editor for Gynecologic Oncology. Dr. Modesitt has published over 120 articles, 20 book chapters/invited articles, and has been recognized annually as a Top Doctor for Cancer since 2012 and an Exceptional Woman in Medicine since 2017.

Her research has focused on hereditary cancers, obesity related cancers, and clinical trials. Outside of work, Dr. Modesitt loves cycling trips, swimming, hiking, golf and, barring injury, does the occasional race.

Academic Appointment

  • Professor and Chair, Gynecology and Obstetrics, Emory University School of Medicine

Education

Degrees

  • MD from University of Virginia
  • BS in Biology, magna cum laude from Emory University

Research

Publications

  • Trustworthiness Criteria for Meta-Analyses of Randomized Controlled Studies: OBGYN Journal Guidelines.
    Gynecol Obstet Invest Volume: 90 Page(s): 1 - 5
    01/01/2025 Authors: OBGYN Editors Integrity Group (OGEIG)
  • Trustworthiness criteria for meta-analyses of randomized controlled studies: OBGYN journal guidelines.
    Ultrasound Obstet Gynecol Volume: 65 Page(s): 9 - 12
    01/01/2025 Authors: OBGYN Editors' Integrity Group (OGEIG)
  • Human Papillomavirus Vaccination in the Postpartum Period: A Systematic Review.
    Obstet Gynecol Volume: 144 Page(s): 782 - 789
    12/01/2024 Authors: Brenner SE; Modesitt S; Bednarczyk RA; Dilley SE
  • Trustworthiness criteria for meta-analyses of randomized controlled studies: OBGYN Journal guidelines.
    Acta Obstet Gynecol Scand Volume: 103 Page(s): 2118 - 2121
    11/01/2024 Authors: OBGYN Editors' Integrity Group (OGEIG); Berghella V
  • Trustworthiness criteria for meta-analyses of randomized controlled studies: OBGYN Journal guidelines.
    Int J Gynaecol Obstet Volume: 167 Page(s): 475 - 478
    11/01/2024 Authors: OBGYN Editors' Integrity Group (OGEIG)
  • The time is now: Concrete actions are needed to improve diversity and representation in clinical trials participation.
    Gynecol Oncol Rep Volume: 55 Page(s): 101513
    10/01/2024 Authors: Dholakia J; Modesitt SC
  • The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology.
    Gynecol Oncol Rep Volume: 55 Page(s): 101477
    10/01/2024 Authors: Anastasio MK; Peters P; Foote J; Melamed A; Modesitt SC; Musa F; Rossi E; Albright BB; Havrilesky LJ; Moss HA
  • Image analysis Uncovers associations between immune landscape, collagen structure, and neoadjuvant chemotherapy in high-grade serous ovarian carcinomas.
    Heliyon Volume: 10 Page(s): e33618
    07/15/2024 Authors: Aggarwal A; Corredor G; Fu P; Pathak T; Mirtti T; Modesitt S; Soong TR; Madabhushi A
  • Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?
    Gynecol Oncol Rep Volume: 53 Page(s): 101383
    06/01/2024 Authors: Roof KA; Andre KE; Modesitt SC; Schirmer DA
  • The more things change, the more they stay the same: The necessity of ensuring gynecologic oncologists remain surgical experts in a changing healthcare environment.
    Gynecol Oncol Rep Volume: 51 Page(s): 101333
    02/01/2024 Authors: Boitano TL; Modesitt SC
  • Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies.
    Commun Med (Lond) Volume: 4 Page(s): 2
    01/03/2024 Authors: Aggarwal A; Khalighi S; Babu D; Li H; Azarianpour-Esfahani S; Corredor G; Fu P; Mokhtari M; Pathak T; Thayer E
  • Gynecologic Oncology Reports: 2022 and beyond.
    Gynecol Oncol Rep Volume: 47 Page(s): 101213
    06/01/2023 Authors: Modesitt SC
  • Condyloma lata mimicking vulvar carcinoma in an immunocompromised patient: A case report.
    Gynecol Oncol Rep Volume: 46 Page(s): 101158
    04/01/2023 Authors: Thayer EG; Roecker ZA; Van Smaalen KM; Mason MC; Modesitt SC
  • Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors.
    Gynecol Oncol Volume: 170 Page(s): 11 - 18
    03/01/2023 Authors: Thomson CA; Crane TE; Miller A; Gold MA; Powell M; Bixel K; Van Le L; DiSilvestro P; Ratner E; Lele S
  • Endometrial Hyperplasia.
    Obstet Gynecol Volume: 140 Page(s): 1061 - 1075
    12/01/2022 Authors: Ring KL; Mills AM; Modesitt SC
  • Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer - Navigating maintenance therapy for homologous recombinant proficient ovarian cancer.
    Gynecol Oncol Rep Volume: 44 Page(s): 101103
    12/01/2022 Authors: Goldsberry WN; Norquist BS; Rocconi RP; Modesitt SC; Urban RR
  • Optimizing post-operative opiate prescribing following gynecologic surgery.
    Gynecol Oncol Rep Volume: 42 Page(s): 101008
    08/01/2022 Authors: Croft KM; Sarosiek BM; Trowbridge E; Page Muthusubramanian C; Hedrick T; Modesitt SC
  • Ridiculously good writing: How to write like a pro and publish like a boss.
    Gynecol Oncol Rep Volume: 42 Page(s): 101024
    08/01/2022 Authors: Modesitt SC; Havrilesky LJ; Previs RA; Alejandro Rauh-Hain J; Michael Straughn J; Bakkum-Gamez JN; Fuh KC; Cohn DE
  • Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
    Am J Obstet Gynecol Volume: 227 Page(s): 61.e1 - 61.e18
    07/01/2022 Authors: Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT
  • Editorial.
    Gynecol Oncol Rep Volume: 39 Page(s): 100932
    02/01/2022 Authors: Modesitt SC
  • Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms.
    Gynecol Oncol Rep Volume: 39 Page(s): 100927
    02/01/2022 Authors: Brett Whalen L; Zachary Wright W; Kundur P; Angadi S; Modesitt SC
  • MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status.
    Int J Gynecol Pathol Volume: 41 Page(s): 1 - 11
    01/01/2022 Authors: Kurpiel B; Thomas MS; Mubeen M; Ring KL; Modesitt SC; Moskaluk CA; Mills AM
  • Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
    Gynecol Oncol Volume: 163 Page(s): 392 - 397
    11/01/2021 Authors: Wenzel L; Huang HQ; Cella D; McKinney CO; Zevon MA; LaChance JA; Walker JL; Salani R; Modesitt SC; Morris RT
  • Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients.
    Cancer Immunol Res Volume: 9 Page(s): 1327 - 1341
    11/01/2021 Authors: Lulu AM; Cummings KL; Jeffery ED; Myers PT; Underwood D; Lacy RM; Chianese-Bullock KA; Slingluff CL; Modesitt SC; Engelhard VH
  • Perioperative Impact of Widespread Implementation of an Enhanced Recovery Protocol on Short-term Outcomes in Cancer Patients.
    J Gastrointest Surg Volume: 25 Page(s): 1316 - 1318
    05/01/2021 Authors: Martin AN; Hassinger TE; Lynch KT; Martin LW; Modesitt SC; Thiele RH; Hedrick TL
  • A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Gynecol Oncol Volume: 160 Page(s): 688 - 695
    03/01/2021 Authors: Duska LR; Krasner CN; O'Malley DM; Hays JL; Modesitt SC; Mathews CA; Moore KN; Thaker PH; Miller A; Purdy C
  • Development and Impact of an Institutional Enhanced Recovery Program on Opioid Use, Length of Stay, and Hospital Costs Within an Academic Medical Center: A Cohort Analysis of 7774 Patients.
    Anesth Analg Volume: 132 Page(s): 442 - 455
    02/01/2021 Authors: Thiele RH; Sarosiek BM; Modesitt SC; McMurry TL; Tiouririne M; Martin LW; Blank RS; Shilling A; Browne JA; Bogdonoff DL
  • "Moving Away From Cancer" Prospective Exercise Trial for Female Rural Cancer Survivors: How Can We Step It Up?
    JCO Oncol Pract Volume: 17 Page(s): e16 - e25
    01/01/2021 Authors: Modesitt SC; Eichner N; Penberthy JK; Horton BJ; Stewart ME; Lacy R; Weltman AL
  • Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?
    Gynecol Oncol Rep Volume: 34 Page(s): 100631
    11/01/2020 Authors: Klavans MR; Erickson SH; Modesitt SC
  • Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
    Int J Gynecol Cancer Volume: 30 Page(s): 1738 - 1747
    11/01/2020 Authors: Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen T-T; Stone RL; Wethington SL; Fader AN
  • If you prescribe it, will they fill it? Options to optimize postoperative opiate prescribing
    Volume: 159 Page(s): 293 - 293
    10/01/2020 Authors: Croft KM; Sarosiek BM; Modesitt SC
  • Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer.
    J Immunother Cancer Volume: 8
    10/01/2020 Authors: Friedman CF; Snyder Charen A; Zhou Q; Carducci MA; Buckley De Meritens A; Corr BR; Fu S; Hollmann TJ; Iasonos A; Konner JA
  • Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling.
    J Obstet Gynaecol Res Volume: 46 Page(s): 1835 - 1841
    09/01/2020 Authors: Garcia C; Sullivan MW; Lothamer H; Harrison KM; Chatfield L; Thomas MH; Modesitt SC
  • Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinic.
    Gynecol Oncol Rep Volume: 33 Page(s): 100587
    08/01/2020 Authors: Knisely AT; Stewart ME; Garcia C; Thomas MH; Modesitt SC; Ring KL
  • Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
    Gynecol Oncol Rep Volume: 32 Page(s): 100569
    05/01/2020 Authors: Podwika SE; Jenkins TM; Khokhar JK; Erickson SH; Modesitt SC
  • Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
    Gynecol Oncol Volume: 156 Page(s): 568 - 574
    03/01/2020 Authors: Beavis AL; Yen T-T; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC
  • Practical Cancer Genetics and Genomics in Women's Health.
    Clin Obstet Gynecol Volume: 62 Page(s): 687 - 699
    12/01/2019 Authors: Modesitt S; Pederson HJ; Adkins RT
  • When to Worry about Cancer: Concurrent Carcinoma and Recurrence in Borderline Ovarian Tumors.
    South Med J Volume: 112 Page(s): 634 - 638
    12/01/2019 Authors: Sullivan MW; Modesitt SC
  • Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.
    Gynecol Oncol Volume: 155 Page(s): 420 - 428
    12/01/2019 Authors: Westin SN; Sill MW; Coleman RL; Waggoner S; Moore KN; Mathews CA; Martin LP; Modesitt SC; Lee S; Ju Z
  • Genetic counseling referral for ovarian cancer patients: a call to action.
    Fam Cancer Volume: 18 Page(s): 303 - 309
    07/01/2019 Authors: Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
  • Cases and evidence for panel testing in cancer genetics: Is site-specific testing dead?
    J Genet Couns Volume: 28 Page(s): 700 - 707
    06/01/2019 Authors: Thomas MH; Higgs LK; Modesitt SC; Schroen AT; Ring KL; Dillon PM
  • Early-stage endometrial cancer with lymphovascular space invasion: Chemotherapy improves progression free survival and reduces distant metastases
    Volume: 154 Page(s): 287 - 288
    06/01/2019 Authors: Yen TT; Beavis AL; Stone RL; Wethington S; Carr CE; Son J; Chambers LJM; Ricci S; Burkett WC; Richardson DL
  • Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.
    Cancer Prev Res (Phila) Volume: 12 Page(s): 401 - 412
    06/01/2019 Authors: Rodriguez GC; Kauderer J; Hunn J; Thaete LG; Watkin WG; Russell S; Yozwiak M; Basil J; Hurteau J; Lele S
  • Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
    Lancet Oncol Volume: 20 Page(s): 862 - 876
    06/01/2019 Authors: Vergote I; Scambia G; O'Malley DM; Van Calster B; Park S-Y; Del Campo JM; Meier W; Bamias A; Colombo N; Wenham RM
  • Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers.
    Gynecol Oncol Rep Volume: 28 Page(s): 18 - 22
    05/01/2019 Authors: Stewart ME; Knisely AT; Sullivan MW; Ring KL; Modesitt SC
  • Physical Activity, Nutrition and Hormone Levels of Postmenopausal Women With and Without Endometrial Cancer
    Volume: 133 Page(s): 202S - 202S
    05/01/2019 Authors: Podwika S; Gabel A; Slack-Davis J; Shupnik M; Hoehn K; Modesitt SC
  • Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).
    Int J Gynecol Pathol Volume: 38 Page(s): 157 - 170
    03/01/2019 Authors: Mills AM; Peres LC; Meiss A; Ring KL; Modesitt SC; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML
  • Enhanced recovery program for minimally invasive and vaginal urogynecologic surgery.
    Int Urogynecol J Volume: 30 Page(s): 313 - 321
    02/01/2019 Authors: Trowbridge ER; Evans SL; Sarosiek BM; Modesitt SC; Redick DL; Tiouririne M; Thiele RH; Hedrick TL; Hullfish KL
  • Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomes.
    Gynecol Oncol Volume: 152 Page(s): 119 - 126
    01/01/2019 Authors: Sullivan MW; Camacho FT; Mills AM; Modesitt SC
  • Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population.
    Hum Pathol Volume: 82 Page(s): 20 - 31
    12/01/2018 Authors: Meiss AE; Thomas M; Modesitt SC; Ring KL; Atkins KA; Mills AM
  • Intussusception as a rare cause of bowel obstruction in a woman with recurrent ovarian cancer.
    Gynecol Oncol Rep Volume: 26 Page(s): 4 - 6
    11/01/2018 Authors: Sullivan MW; Modesitt SC
  • Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas.
    Mod Pathol Volume: 31 Page(s): 1282 - 1290
    08/01/2018 Authors: Mills A; Zadeh S; Sloan E; Chinn Z; Modesitt SC; Ring KL
  • Endometrial cancer in an increasingly obese population: Exploring alternative options when surgery may not cut it.
    Gynecol Oncol Rep Volume: 25 Page(s): 30 - 34
    08/01/2018 Authors: Staples JN; Rauh L; Peach MS; Baker WD; Modesitt SC
  • Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.
    Gynecol Oncol Volume: 150 Page(s): 300 - 305
    08/01/2018 Authors: Ahmed A; Deng W; Tew W; Bender D; Mannel RS; Littell RD; DeNittis AS; Edelson M; Morgan M; Carlson J
  • Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol Volume: 150 Page(s): 119 - 126
    07/01/2018 Authors: von Gruenigen VE; Huang HQ; Cella D; Zevon M; LaChance JA; Walker JL; Salani R; Modesitt SC; Morris RT; Bradley WH
  • Moving away from cancer exercise trial for overweight/obese cancer survivors: Predicting immediate dropout rates
    Volume: 149 Page(s): 117 - 117
    06/01/2018 Authors: Modesitt SC; Eichner NZ; Penberthy JK; Evans E; Lacy RM; Stewart ME; Weltman AL
  • Behind every mammo there's an MRI: Evaluation of high-risk breast cancer screening strategies in BRCA mutation carriers
    Volume: 149 Page(s): 213 - 214
    06/01/2018 Authors: Knisely AT; Stewart ME; Harrison KM; Garcia C; Thomas MH; Modesitt SC; Ring KL
  • Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling
    Volume: 149 Page(s): 180 - 181
    06/01/2018 Authors: Garcia C; Lothamer H; Harrison KM; Sullivan MW; Thomas MH; Modesitt SC
  • Evaluation of Screening and Risk Reducing Surgery for Women Followed in a High Risk Breast/Ovarian Cancer Clinic
    Volume: 131 Page(s): 15S - 15S
    05/01/2018 Authors: Stewart ME; Knisely AT; Sullivan MW; Ring KL; Modesitt SC
  • Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
    Obstet Gynecol Clin North Am Volume: 45 Page(s): 155 - 173
    03/01/2018 Authors: Ring KL; Modesitt SC
  • Vaginal sarcoidosis without other organ involvement in a patient with a history of endometrial cancer: A case report.
    Gynecol Oncol Rep Volume: 23 Page(s): 34 - 36
    02/01/2018 Authors: Knisely AT; Girton MR; Hintz HC; Modesitt SC
  • Analysis of the circular RNA transcriptome in endometrial cancer.
    Oncotarget Volume: 9 Page(s): 5786 - 5796
    01/19/2018 Authors: Chen BJ; Byrne FL; Takenaka K; Modesitt SC; Olzomer EM; Mills JD; Farrell R; Hoehn KL; Janitz M
  • Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer.
    Gynecol Oncol Volume: 147 Page(s): 654 - 662
    12/01/2017 Authors: Chen BJ; Byrne FL; Takenaka K; Modesitt SC; Olzomer EM; Mills JD; Farrell R; Hoehn KL; Janitz M
  • Current and future role of genetic screening ingynecologic malignancies.
    Am J Obstet Gynecol Volume: 217 Page(s): 512 - 521
    11/01/2017 Authors: Ring KL; Garcia C; Thomas MH; Modesitt SC
  • Hereditary Breast and Ovarian Cancer Syndrome
    OBSTETRICS AND GYNECOLOGY Volume: 130 Page(s): E110 - E126
    09/01/2017 Authors: Modesitt SC; Lu K; Chen L-M; Powell CB
  • The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis.
    Gynecol Oncol Volume: 146 Page(s): 642 - 646
    09/01/2017 Authors: Turner TB; Dilley SE; Smith HJ; Huh WK; Modesitt SC; Rose SL; Rice LW; Fowler JM; Straughn JM
  • Missing the grade: Correlation of unknown grade with patient demographics, hospital type, and cancer outcomes in epithelial ovarian cancer
    Volume: 145 Page(s): 130 - 131
    06/01/2017 Authors: Sullivan MW; Camacho F; Schildkraut JM; Modesitt SC
  • The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis
    Volume: 145 Page(s): 6 - 6
    06/01/2017 Authors: Turner TB; Dilley SE; Smith HJ; Huh WK; Modesitt SC; Rose SL; Rice LW; Fowler JM; Straughn JM
  • One of these things is not like the others: PD-L1 expression in Lynch syndrome associated and sporadic mismatch repair deficient endometrial carcinomas
    Volume: 145 Page(s): 37 - 37
    06/01/2017 Authors: Ring KL; Sloan EA; Willis BC; Modesitt SC; Mills AM
  • PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
    Am J Surg Pathol Volume: 41 Page(s): 326 - 333
    03/01/2017 Authors: Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
  • PD-L1 Expression in Mismatch Repair-Deficient Endometrial Carcinomas, Including Lynch Syndrome-Associated and Sporadic MLH1 Promoter Hypermethylated Tumors
    Volume: 97 Page(s): 309A - 309A
    02/01/2017 Authors: Sloan EA; Ring K; Willis BC; Modesitt SC; Mills A
  • PD-L1 Expression in Mismatch Repair-Deficient Endometrial Carcinomas, Including Lynch Syndrome-Associated and Sporadic MLH1 Promoter Hypermethylated Tumors
    Volume: 30 Page(s): 309A - 309A
    02/01/2017 Authors: Sloan EA; Ring K; Willis BC; Modesitt SC; Mills A
  • The emerging role of long non-coding RNAs in endometrial cancer.
    Cancer Genet Volume: 209 Page(s): 445 - 455
    10/01/2016 Authors: Takenaka K; Chen BJ; Modesitt SC; Byrne FL; Hoehn KL; Janitz M
  • Hormonal Contraceptives for Endometrial Cancer Prevention in Obese and High-Risk Women in Virginia.
    South Med J Volume: 109 Page(s): 621 - 627
    10/01/2016 Authors: Horst KE; Modesitt SC
  • Enhanced Recovery Implementation in Major Gynecologic Surgeries: Effect of Care Standardization.
    Obstet Gynecol Volume: 128 Page(s): 457 - 466
    09/01/2016 Authors: Modesitt SC; Sarosiek BM; Trowbridge ER; Redick DL; Shah PM; Thiele RH; Tiouririne M; Hedrick TL
  • Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia.
    Am J Obstet Gynecol Volume: 214 Page(s): 752.e1 - 752.e6
    06/01/2016 Authors: Cuff RD; Buchanan T; Pelkofski E; Korte J; Modesitt SP; Pierce JY
  • Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Am J Surg Pathol Volume: 40 Page(s): 155 - 165
    02/01/2016 Authors: Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
  • Clinicopathologic Comparison of Lynch Syndrome-Associated and "Lynch-Like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry
    Volume: 96 Page(s): 297A - 297A
    02/01/2016 Authors: Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
  • Clinicopathologic Comparison of Lynch Syndrome-Associated and "Lynch-Like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry
    Volume: 29 Page(s): 297A - 297A
    02/01/2016 Authors: Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
  • Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.
    Gynecol Oncol Volume: 140 Page(s): 184 - 190
    01/01/2016 Authors: Secord AA; Hasselblad V; Von Gruenigen VE; Gehrig PA; Modesitt SC; Bae-Jump V; Havrilesky LJ
  • Women at extreme risk for obesity-related carcinogenesis: Baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life.
    Gynecol Oncol Volume: 138 Page(s): 238 - 245
    08/01/2015 Authors: Modesitt SC; Hallowell PT; Slack-Davis JK; Michalek RD; Atkins KA; Kelley SL; Arapovic S; Shupnik MA; Hoehn K
  • Changes in metabolic profiles before and after bariatric surgery in high risk morbidly obese women: Obesity-related carcinogenesis is not all about hormones
    Volume: 137 Page(s): 26 - 26
    03/01/2015 Authors: Modesitt SC; Hallowell PT; Hoehn KL; Slack-Davis JK; Kelley SL; Arapovic S; Shupnik M
  • Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy.
    Case Rep Obstet Gynecol Volume: 2015 Page(s): 760429
    01/01/2015 Authors: Vaughan MH; Modesitt SC; Mo Y; Trowbridge ER
  • What is new in endometrial hyperplasia treatment or prevention? Best articles from the past year.
    Obstet Gynecol Volume: 124 Page(s): 1029 - 1030
    11/01/2014 Authors: Modesitt SC
  • Metabolic vulnerabilities in endometrial cancer.
    Cancer Res Volume: 74 Page(s): 5832 - 5845
    10/15/2014 Authors: Byrne FL; Poon IKH; Modesitt SC; Tomsig JL; Chow JDY; Healy ME; Baker WD; Atkins KA; Lancaster JM; Marchion DC
  • The North American Menopause Society recommendations for clinical care of midlife women.
    Menopause Volume: 21 Page(s): 1038 - 1062
    10/01/2014 Authors: Shifren JL; Gass MLS; NAMS Recommendations for Clinical Care of Midlife Women Working Group
  • Hormonal Contraceptive Use for Endometrial Cancer Prevention Physician Attitudes and Practices
    Volume: 123 Page(s): 183S - 183S
    05/01/2014 Authors: Horst KE; Modesitt SC
  • Perceptions of obesity and cancer risk in female bariatric surgery candidates: highlighting the need for physician action for unsuspectingly obese and high risk patients.
    Gynecol Oncol Volume: 133 Page(s): 73 - 77
    04/01/2014 Authors: Henretta MS; Copeland AR; Kelley SL; Hallowell PT; Modesitt SC
  • Obesity crisis in cancer care: gynecologic cancer prevention, treatment, and survivorship in obese women in the United States.
    Gynecol Oncol Volume: 133 Page(s): 1 - 3
    04/01/2014 Authors: Modesitt S; Walker J
  • Desmoplastic small round cell tumor of the ovary: A rare but devastating disease in young women.
    Gynecol Oncol Case Rep Volume: 7 Page(s): 16 - 18
    01/01/2014 Authors: Nakayama J; Nassau S; Atkins K; Modesitt SC
  • Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924.
    Mol Cancer Ther Volume: 12 Page(s): 1958 - 1967
    10/01/2013 Authors: Jazaeri AA; Shibata E; Park J; Bryant JL; Conaway MR; Modesitt SC; Smith PG; Milhollen MA; Berger AJ; Dutta A
  • In reply.
    Obstet Gynecol Volume: 122 Page(s): 394
    08/01/2013 Authors: Modesitt SC
  • Post Approval Human Papillomavirus Vaccine Uptake Is Higher in Minorities Compared to Whites in Girls Presenting for Well-Child Care.
    Vaccines (Basel) Volume: 1 Page(s): 250 - 261
    07/17/2013 Authors: Pierce JY; Korte JE; Carr LA; Gasper CB; Modesitt SC
  • Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
    Int J Gynecol Cancer Volume: 23 Page(s): 853 - 860
    06/01/2013 Authors: Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
  • Overcoming platinum resistance in ovarian cancer using the novel compound MLN4924.
    Volume: 73
    04/15/2013 Authors: Jazaeri AA; Shibata E; Park J; Bryant J; Conaway MR; Modesitt SC; Smith PG; Milhollen M; Berger AJ; Dutta A
  • A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.
    Gynecol Oncol Volume: 129 Page(s): 86 - 91
    04/01/2013 Authors: Schilder RJ; Sill MW; Lankes HA; Gold MA; Mannel RS; Modesitt SC; Hanjani P; Bonebrake AJ; Sood AK; Godwin AK
  • What is new in gynecologic oncology?: thought-provoking articles from the past year.
    Obstet Gynecol Volume: 121 Page(s): 872 - 873
    04/01/2013 Authors: Modesitt SC
  • Vulvar necrotizing soft tissue infection: A review of a multi-disciplinary surgical emergency and management in the modern era.
    Gynecol Oncol Case Rep Volume: 5 Page(s): 6 - 9
    01/01/2013 Authors: Courtney-Brooks M; Scalici J; Henretta MS; Modesitt SC; Jazaeri AA; Cantrell LA; Duska LR
  • Missed opportunities for primary endometrial cancer prevention: how to optimize early identification and treatment of high-risk women.
    Obstet Gynecol Volume: 120 Page(s): 989 - 991
    11/01/2012 Authors: Modesitt SC
  • Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.
    Gynecol Oncol Volume: 127 Page(s): 326 - 331
    11/01/2012 Authors: Giugale LE; Di Santo N; Smolkin ME; Havrilesky LJ; Modesitt SC
  • Hyperandrogenism of ovarian etiology: utilizing differential venous sampling for diagnosis.
    Obstet Gynecol Volume: 120 Page(s): 476 - 479
    08/01/2012 Authors: Bailey AP; Schutt AK; Carey RM; Angle JF; Modesitt SC
  • Frailty: an outcome predictor for elderly gynecologic oncology patients.
    Gynecol Oncol Volume: 126 Page(s): 20 - 24
    07/01/2012 Authors: Courtney-Brooks M; Tellawi AR; Scalici J; Duska LR; Jazaeri AA; Modesitt SC; Cantrell LA
  • Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer.
    Int J Gynecol Cancer Volume: 22 Page(s): 732 - 741
    06/01/2012 Authors: Modesitt SC; Hsu JY; Chowbina SR; Lawrence RT; Hoehn KL
  • Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones?
    Gynecol Oncol Volume: 124 Page(s): 431 - 436
    03/01/2012 Authors: Modesitt SC; Geffel DL; Via J; L Weltman A
  • Coexisting atypical polypoid adenomyoma and endometrioid endometrial carcinoma in a young woman with Cowden Syndrome: Case report and implications for screening and prevention.
    Gynecol Oncol Case Rep Volume: 2 Page(s): 29 - 31
    01/01/2012 Authors: Edwards JM; Alsop S; Modesitt SC
  • Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
    Lancet Oncol Volume: 12 Page(s): 1109 - 1117
    11/01/2011 Authors: Coleman RL; Duska LR; Ramirez PT; Heymach JV; Kamat AA; Modesitt SC; Schmeler KM; Iyer RB; Garcia ME; Miller DL
  • Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.
    Gynecol Oncol Volume: 123 Page(s): 65 - 70
    10/01/2011 Authors: Convery PA; Cantrell LA; Di Santo N; Broadwater G; Modesitt SC; Secord AA; Havrilesky LJ
  • Hormone replacement therapy in gynecologic cancer survivors: why not?
    Gynecol Oncol Volume: 122 Page(s): 447 - 454
    08/01/2011 Authors: Ibeanu O; Modesitt SC; Ducie J; von Gruenigen V; Agueh M; Fader AN
  • Phase II multi-institutional study of docetaxel plus aflibercept (AVE0005, NSC# 724770) in patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer.
    Volume: 29
    05/20/2011 Authors: Coleman RL; Duska LR; Ramirez PT; Modesitt SC; Schmeler KM; Iyer R; Garcia M; Sood A
  • A nomogram for estimating the probability of ovarian cancer.
    Gynecol Oncol Volume: 121 Page(s): 2 - 7
    04/01/2011 Authors: Lachance JA; Choudhri AF; Sarti M; Modesitt SC; Jazaeri AA; Stukenborg GJ
  • Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    J Reprod Med Volume: 56 Page(s): 376 - 380
    01/01/2011 Authors: DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
  • Appendiceal pathology at the time of oophorectomy for ovarian neoplasms.
    Obstet Gynecol Volume: 116 Page(s): 1348 - 1353
    12/01/2010 Authors: Timofeev J; Galgano MT; Stoler MH; Lachance JA; Modesitt SC; Jazaeri AA
  • Florid endometriosis in a postmenopausal woman.
    Fertil Steril Volume: 94 Page(s): 2769.e1 - 2769.e4
    12/01/2010 Authors: Bailey AP; Schutt AK; Modesitt SC
  • Cervical stromal invasion predicting survival in endometrial cancer.
    Obstet Gynecol Volume: 116 Page(s): 1035 - 1041
    11/01/2010 Authors: Ferriss JS; Brix W; Tambouret R; DeSimone CP; Stoler M; Modesitt SC
  • In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: does timing matter?
    Gynecol Oncol Volume: 119 Page(s): 351 - 357
    11/01/2010 Authors: Modesitt SC; Parsons SJ
  • SGO White Paper on ovarian cancer: etiology, screening and surveillance.
    Gynecol Oncol Volume: 119 Page(s): 7 - 17
    10/01/2010 Authors: Schorge JO; Modesitt SC; Coleman RL; Cohn DE; Kauff ND; Duska LR; Herzog TJ
  • Pre-operative gynecologic evaluation of bariatric surgery patients: improving cancer detection in a high-risk population.
    J Am Coll Surg Volume: 211 Page(s): 256 - 262
    08/01/2010 Authors: Winfree LE; Henretta MS; Hallowell PT; Modesitt SC
  • Anomalous vasculature in Mayer-Rokitansky-Kuster-Hauser syndrome.
    Fertil Steril Volume: 94 Page(s): 350.e1 - 350.e4
    06/01/2010 Authors: Bailey AP; Young JL; Nigrini E; Modesitt SC
  • Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
    Gynecol Oncol Volume: 116 Page(s): 126 - 130
    01/01/2010 Authors: Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG
  • Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series.
    Int J Gynecol Cancer Volume: 20 Page(s): 120 - 125
    01/01/2010 Authors: Ferriss JS; Atkins KA; Lachance JA; Modesitt SC; Jazaeri AA
  • Cancer in obese women: potential protective impact of bariatric surgery.
    J Am Coll Surg Volume: 208 Page(s): 1093 - 1098
    06/01/2009 Authors: McCawley GM; Ferriss JS; Geffel D; Northup CJ; Modesitt SC
  • Cancer in obese women: The potential protective impact of bariatric surgery
    Volume: 112 Page(s): S69 - S69
    02/01/2009 Authors: McCawley GM; Ferriss S; Geffel D; Northup CJ; Modesitt SC
  • Appendectomy in the setting of a pelvic mass: Are ovarian frozen pathology and gross appearance of the appendix predictive of coexisting appendiceal pathology?
    Volume: 112 Page(s): S102 - S103
    02/01/2009 Authors: Jazaeri AA; Timofeev J; Galgano MT; Stoler M; Lachance JA; Andersen WA; Modesitt SC
  • In vitro and in vivo vorinostat with and without paclitaxel in ovarian cancer models
    Volume: 112 Page(s): S136 - S136
    02/01/2009 Authors: Modesitt SC; Dunlap-Brown M; Stoops T; Brautigan DL
  • A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
    Gynecol Oncol Volume: 109 Page(s): 182 - 186
    05/01/2008 Authors: Modesitt SC; Sill M; Hoffman JS; Bender DP; Gynecologic Oncology Group
  • Cyclooxygenase-2 in cervical neoplasia: a review.
    Gynecol Oncol Volume: 109 Page(s): 140 - 145
    04/01/2008 Authors: Young JL; Jazaeri AA; Darus CJ; Modesitt SC
  • A multivariable analysis model for preoperative prediction of ovarian cancer in adnexal masses
    Volume: 108 Page(s): S134 - S134
    03/01/2008 Authors: Lachance JA; Stukenborg GJ; Choudri A; Sarti M; Modesitt SC; Jazaeri AA
  • Loop electrosurgical excision procedure margin status and human papillomavirus in recurrent cervical dysplasia
    Volume: 108 Page(s): S154 - S154
    03/01/2008 Authors: Carr AH; Darracott MM; Lachance J; Young J; Irvin WP; Modesitt SC
  • Hypodontia as a risk marker for epithelial ovarian cancer: a case-controlled study.
    J Am Dent Assoc Volume: 139 Page(s): 163 - 169
    02/01/2008 Authors: Chalothorn LA; Beeman CS; Ebersole JL; Kluemper GT; Hicks EP; Kryscio RJ; DeSimone CP; Modesitt SC
  • The effects of abuse on health problems in menopausal women.
    Menopause Volume: 15 Page(s): 1 - 4
    01/01/2008 Authors: Pinkerton JV; Dougherty P; Modesitt SC
  • Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.
    Expert Opin Pharmacother Volume: 8 Page(s): 2293 - 2305
    10/01/2007 Authors: Modesitt SC; Jazaeri AA
  • Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Am J Obstet Gynecol Volume: 197 Page(s): 195.e1 - 195.e7
    08/01/2007 Authors: Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
  • Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
    Gynecol Oncol Volume: 105 Page(s): 59 - 65
    04/01/2007 Authors: Modesitt SC; Tian C; Kryscio R; Thigpen JT; Randall ME; Gallion HH; Fleming GF; Gynecologic Oncology Group
  • In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer.
    Gynecol Oncol Volume: 104 Page(s): 596 - 601
    03/01/2007 Authors: Cooper AL; Greenberg VL; Lancaster PS; van Nagell JR; Zimmer SG; Modesitt SC
  • Primary appendiceal cancer: gynecologic manifestations and treatment options.
    Gynecol Oncol Volume: 104 Page(s): 602 - 606
    03/01/2007 Authors: Dietrich CS; Desimone CP; Modesitt SC; Depriest PD; Ueland FR; Pavlik EJ; Kryscio R; Cibull M; Huh W; Partridge E
  • The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus.
    Gynecol Oncol Volume: 104 Page(s): 390 - 395
    02/01/2007 Authors: DeSimone CP; Van Ness JS; Cooper AL; Modesitt SC; DePriest PD; Ueland FR; Pavlik EJ; Kryscio RJ; van Nagell JR
  • Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.
    Int J Gynecol Cancer Volume: 17 Page(s): 886 - 889
    01/01/2007 Authors: Huh WK; Straughn JM; Mariani A; Podratz KC; Havrilesky LJ; Alvarez-Secord A; Gold MA; McMeekin DS; Modesitt S; Cooper AL
  • Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases.
    Gynecol Oncol Volume: 103 Page(s): 755 - 758
    11/01/2006 Authors: Freeman SA; Modesitt SC
  • Food insecurity among cancer patients in kentucky: a pilot study.
    J Oncol Pract Volume: 2 Page(s): 274 - 279
    11/01/2006 Authors: Simmons LA; Modesitt SC; Brody AC; Leggin AB
  • Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence.
    Gynecol Oncol Volume: 103 Page(s): 300 - 306
    10/01/2006 Authors: Modesitt SC; Huang B; Shelton BJ; Wyatt S
  • The incidental postmenopausal adnexal mass.
    Clin Obstet Gynecol Volume: 49 Page(s): 506 - 516
    09/01/2006 Authors: McDonald JM; Modesitt SC
  • Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis.
    Fertil Steril Volume: 86 Page(s): 535 - 542
    09/01/2006 Authors: Smedts AM; Lele SM; Modesitt SC; Curry TE
  • Concordance of gross surgical and final fixed margins in vulvar intraepithelial neoplasia 3 and vulvar cancer.
    J Reprod Med Volume: 51 Page(s): 617 - 620
    08/01/2006 Authors: DeSimone CP; Crisp MP; Ueland FR; DePriest PD; van Nagell JR; Lele SM; Modesitt SC
  • Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer.
    Obstet Gynecol Volume: 107 Page(s): 1330 - 1336
    06/01/2006 Authors: Modesitt SC; Gambrell AC; Cottrill HM; Hays LR; Walker R; Shelton BJ; Jordan CE; Ferguson JE
  • Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature.
    Obstet Gynecol Volume: 107 Page(s): 1285 - 1291
    06/01/2006 Authors: DeSimone CP; Day ME; Tovar MM; Dietrich CS; Eastham ML; Modesitt SC
  • Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Obstet Gynecol Volume: 107 Page(s): 71 - 76
    01/01/2006 Authors: Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
  • The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Gynecol Oncol Volume: 99 Page(s): 557 - 563
    12/01/2005 Authors: Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J
  • The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
    Obstet Gynecol Surv Volume: 60 Page(s): 683 - 692
    10/01/2005 Authors: Modesitt SC; van Nagell JR
  • Expression of an extracellular, matrix metalloproteinase-inducer (basigin) in ovarian endometriosis.
    Page(s): 128 - 128
    01/01/2005 Authors: Smedts AM; Lele SM; Modesitt SC; Curry TE
  • Positron emission tomography in a premenopausal asymptomatic woman: a case report of increased ovarian uptake in a benign condition.
    Int J Gynecol Cancer Volume: 15 Page(s): 1127 - 1130
    01/01/2005 Authors: Cottrill HM; Fitzcharles EK; Modesitt SC
  • Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter.
    Obstet Gynecol Volume: 102 Page(s): 594 - 599
    09/01/2003 Authors: Modesitt SC; Pavlik EJ; Ueland FR; DePriest PD; Kryscio RJ; van Nagell JR
  • Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy.
    Gynecol Oncol Volume: 89 Page(s): 543 - 548
    06/01/2003 Authors: DeSimone CP; Lele SM; Modesitt SC
  • Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
    Gynecol Oncol Volume: 87 Page(s): 1 - 7
    10/01/2002 Authors: Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV
  • Ovarian and extraovarian endometriosis-associated cancer.
    Obstet Gynecol Volume: 100 Page(s): 788 - 795
    10/01/2002 Authors: Modesitt SC; Tortolero-Luna G; Robinson JB; Gershenson DM; Wolf JK
  • Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies.
    Gynecol Oncol Volume: 85 Page(s): 285 - 291
    05/01/2002 Authors: Ramirez PT; Modesitt SC; Morris M; Edwards CL; Bevers MW; Wharton JT; Wolf JK
  • Endovascular management of ureteral-iliac artery fistulae with Wallgraft endoprostheses.
    Gynecol Oncol Volume: 85 Page(s): 212 - 217
    04/01/2002 Authors: Madoff DC; Toombs BD; Skolkin MD; Bodurka DC; Modesitt SC; Wood CG; Hicks ME
  • In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
    Clin Cancer Res Volume: 7 Page(s): 1765 - 1772
    06/01/2001 Authors: Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK
  • Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors.
    Gynecol Oncol Volume: 76 Page(s): 51 - 55
    01/01/2000 Authors: Modesitt SC; Groben PA; Walton LA; Fowler WC; Van Le L
  • Vulvar intraepithelial neoplasia III: Occult cancer and the impact of margin status on recurrence - Reply
    OBSTETRICS AND GYNECOLOGY Volume: 93 Page(s): 633 - 634
    04/01/1999 Authors: Modesitt SC; Van Le L
  • Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence.
    Obstet Gynecol Volume: 92 Page(s): 962 - 966
    12/01/1998 Authors: Modesitt SC; Waters AB; Walton L; Fowler WC; Van Le L
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements